OCC Meeting Summary with BlackRock

The Office of the Comptroller of the Currency (OCC) has published a summary of a meeting held on March 18, 2026, with BlackRock. This notice provides a record of the discussion topics between the OCC and representatives from the asset management firm.

OCC Meeting Summary with Stripe

The Office of the Comptroller of the Currency (OCC) has published a summary of a meeting held with Stripe on March 23, 2026. The document details discussions held between OCC officials and Stripe representatives regarding various topics relevant to the financial services industry.

NCLAT Chennai Bench Supplementary Cause List - March 24, 2026

The National Company Law Appellate Tribunal (NCLAT) Chennai Bench has issued a supplementary cause list for March 24, 2026. This list details the cases scheduled for hearing and judgment delivery, including specific case numbers, parties involved, and counsel.

NCLAT Supplementary Cause List for March 24, 2026

The National Company Law Appellate Tribunal (NCLAT) has issued a supplementary cause list for March 24, 2026. This document outlines the cases scheduled for judgment, admission, and hearing before the Chairperson's court, along with instructions for video conferencing proceedings.

NCLAT Supplementary Cause List for March 24, 2026

The National Company Law Appellate Tribunal (NCLAT) has issued a supplementary cause list for its Principal Bench, Court II, scheduled for March 24, 2026. The notice provides instructions for joining video conference hearings, including appearance slip submission and technical support contacts.

NCLAT Supplementary Cause List - Court III

The National Company Law Appellate Tribunal (NCLAT) has issued a supplementary cause list for Court III, scheduled for March 24, 2026. The document outlines instructions for smooth virtual hearings, including joining procedures, appearance slip submission, and technical support contacts.

NCLAT Court IV Supplementary Cause List for March 24, 2026

The National Company Law Appellate Tribunal (NCLAT) has issued a supplementary cause list for Court IV, scheduled for March 24, 2026. The document outlines the cases to be heard, including those for judgment, and provides instructions for participating in hybrid mode video conferencing hearings.

NCLAT Chennai Daily Cause List - March 25, 2026

The National Company Law Appellate Tribunal (NCLAT) Chennai Bench has published its daily cause list for March 25, 2026. The document outlines the cases scheduled for hearing, including those for admission, stay, orders, and defective cases, indicating routine judicial proceedings.

USPTO Grants Patent for ACE Inhibitor and Blood Pressure-Lowering Agent

The USPTO has granted a patent (US12582146B2) to MARUZEN PHARMACEUTICALS CO., LTD. for an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent containing a specific compound. The patent also covers beverages and food products incorporating this compound.

USPTO Patent Grant: Topical Anti-inflammatory Composition with Zileuton

The USPTO has granted a patent (US12582598B2) to QURIENT CO., LTD. for a topical anti-inflammatory pharmaceutical composition comprising Zileuton. The patent covers the composition, its uses, and methods of preparation.